MedPath

Contraceptive Pathway and Contraception Continuation Rates

Not Applicable
Suspended
Conditions
Contraceptive Usage
Interventions
Other: COntraceptive pathway
Registration Number
NCT03925116
Lead Sponsor
Rutgers, The State University of New Jersey
Brief Summary

Women seeking contraception will be randomized to "usual care" or to a "Contraceptive Pathway"

Detailed Description

Patients who present to the gynecology clinic for an annual, postpartum or contraceptive visit will be asked if they are interested in obtaining contraception by the front desk staff. If they respond yes, they will be seen in a triage or exam room by study personnel/medical assistant (MA) who will ask them if they would like to participate in the study, review the study and then randomize them to either the contraceptive pathway or usual care. The randomization will be done by opening sequentially numbered envelopes once they consent and while in the triage/exam room.

Patients triaged to the pathway will be handed an electronic tablet questionnaire while they are waiting to see the physician/(Advanced practice nurse (APN). The tablet contains a link to bedside.org, a public website which reviews contraceptive options. Vital signs will be collected as per usual care and recorded on both the questionnaire and in the electronic medical record(EMR). Study personnel will be available to offer the patient additional information on their choice of contraception or assist them with the link for information. The completed survey will be printed and placed in the subject room for review by the physician/APN. A copy will be kept in the subject binder and another will be scanned into the EMR.

Patients triaged to usual care will wait for their physician without the pathway questionnaire and will be asked the usual questions by the MA which will be recorded in the EMR. Vital signs will be collected and recorded in the EMR.

The physician/APN will see the subject as usual, review either the questionnaire or the EMR, review contraception options and initiate the contraception.

At completion of the visit, all woman will be asked if she would complete a satisfaction survey for her visit. She will be called at 2 weeks, 3, 6 and 12 months to discuss contraception initiation and continuation.

Recruitment & Eligibility

Status
SUSPENDED
Sex
Female
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Contraceptive pathwayCOntraceptive pathwayWomen who present for birth control to the gynecology office will be recognized by the front desk and offered a tablet which which will: 1. collect relevant medical history 2. provide educational material on birth control options 3. provide a link to bedsider.com for further information They will then discuss the tablet information/history with the medical assistant, who will answer any remaining questions. They will then see the physician/APN. Follow up phone call will be done at 2 weeks, 3, 6 and 12 months to discuss contraception initiation and continuation.
Primary Outcome Measures
NameTimeMethod
Continued Use of Contraception at 1 year1 year

The difference in contraception continuation rates will be compared between the Contraceptive Pathway group and the Usual care group, based on follow up phone calls at 3 weeks, 6 months and 1 year

Secondary Outcome Measures
NameTimeMethod
Pregnancy rates1 year

At each phone call, interval pregnancy rates will be collected and compared between subjects in the Contraceptive pathway vs usual care

Subject satisfaction with contraceptive counselingat initial office visit/immediate

Subjects will complete a Likert scale 1 - 5 with 1 being most and 5 being least satisfied with the contraceptive counseling. Responses will be compared between the Contraceptive Pathway and Usual care group

Trial Locations

Locations (1)

Clinical Academic Building. 125 Paterson Street

🇺🇸

New Brunswick, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath